Showing results (1-10 of 79) with videos related to
Sort By:
Pageof 8
Journal of Neuroscience Research|December 31, 2008
Effect of estradiol on striatal dopamine activity of female hemiparkinsonian monkeysMarc Morissette, Thérèse Di PaoloJournal of Neural Transmission (Vienna, Austria : 1996)|April 10, 2017
Non-human primate models of PD to test novel therapiesMarc Morissette, Thérèse Di PaoloNeuroscience and Biobehavioral Reviews|December 29, 2015
Neuroactive gonadal drugs for neuroprotection in male and female models of Parkinson's diseaseNadhir Litim, Marc Morissette, Thérèse Di PaoloNeuropharmacology|April 9, 2016
Metabotropic glutamate receptors as therapeutic targets in Parkinson's disease: An update from the last 5 years of researchNadhir Litim, Marc Morissette, Thérèse Di PaoloNeurobiology of Aging|April 15, 2014
Raloxifene activates G protein-coupled estrogen receptor 1/Akt signaling to protect dopamine neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine miceMélanie Bourque, Marc Morissette, Thérèse Di PaoloNeuropharmacology|February 14, 2017
Effects of progesterone administered after MPTP on dopaminergic neurons of male miceNadhir Litim, Marc Morissette, Thérèse Di PaoloNeuropharmacology|April 13, 2018
Repurposing sex steroids and related drugs as potential treatment for Parkinson's diseaseMélanie Bourque, Marc Morissette, Thérèse Di PaoloNeuropharmacology|November 30, 2004
Effect of estrogen receptor agonists treatment in MPTP mice: evidence of neuroprotection by an ER alpha agonistMyreille D'Astous, Marc Morissette, Thérèse Di PaoloNeuropharmacology|April 21, 2015
Neuroprotection in Parkinsonian-treated mice via estrogen receptor α activation requires G protein-coupled estrogen receptor 1Mélanie Bourque, Marc Morissette, Thérèse Di PaoloNeuroscience and Biobehavioral Reviews|November 25, 2023
Neuroactive steroids and Parkinson's disease: Review of human and animal studiesMélanie Bourque, Marc Morissette, Thérèse Di PaoloPageof 8